Wegovy Pill vs Ozempic

Side-by-side on efficacy, form, dosing, side effects, and 2026 cash-pay and insurance pricing.

Wegovy PillOzempic
Active ingredientSemaglutideSemaglutide
FormDaily pillInjection
Avg weight loss~15%~10–14%
Cash price / mo$149–$299$349/mo
FDA for obesityApprovedOff-label
Bottom line

Same active ingredient (semaglutide), different routes and indications. Ozempic (injection, 2.0 mg weekly) is on-label for diabetes. The Wegovy Pill (oral, 25 mg daily) is on-label for weight loss. If weight loss is the goal and you want oral, pill wins on alignment. If diabetes is the goal, Ozempic wins on evidence and insurance.

Who wins on what

Weight loss (non-diabetics)
13.6% oral at 25 mg vs ~10–14% Ozempic 2.0 mg off-label
Wegovy Pill
Type 2 diabetes
Ozempic is on-label with CV outcomes data
Ozempic
No needles
Oral tablet
Wegovy Pill
Insurance coverage for obesity
On-label indication matches coverage
Wegovy Pill

Two doses of the same drug

Semaglutide comes in three FDA-approved forms in the U.S.: Ozempic (injection, diabetes), Wegovy (injection, obesity), and Rybelsus + Wegovy Pill (oral, diabetes at 3/7/14 mg and obesity at 25 mg respectively). All are Novo Nordisk, all are semaglutide.

The pill-vs-injection comparison depends on what you're treating. For obesity specifically, the Wegovy Pill is the on-label oral choice; Ozempic's use would be off-label and typically uncovered for obesity coding.

Frequently asked questions

Is the Wegovy Pill the same as Ozempic?

Same active ingredient (semaglutide). Different doses, routes, and indications. Ozempic is 0.25–2.0 mg weekly injection for diabetes. Wegovy Pill is 25 mg daily oral for weight loss.

Can I use the Wegovy Pill instead of Ozempic for diabetes?

Not on-label. Rybelsus (3/7/14 mg oral semaglutide) is the oral diabetes form. The 25 mg Wegovy Pill is approved only for chronic weight management.

Not sure which is right for you? Take the Sherpa Matcher — it accounts for your goals, budget, and insurance in 60 seconds.